Substituted urea retinoid agonists

Details Substituted urea retinoid agonists Substituted urea retinoid agonists

2005-01-04

2005-01-04

Huang, Evelyn Mei (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S378000, C514S438000, C514S585000, C514S586000, C514S535000, C514S564000, C514S567000, C514S596000, C514S598000, C514S534000, C514S423000, C514S562000, C514S317000, C546S306000, C546S205000, C548S247000, C548S530000, C549S077000, C560S034000, C560S016000, C562S439000, C564S026000, C564S034000, C564S048000, C564S049000, C564S163000

Reexamination Certificate

active

06838472

ABSTRACT:
The current invention provide novel compounds, methods of treating or preventing emphysema, cancer and dermatological disorders, pharmaceutical compositions suitable for the treatment or prevention of emphysema, cancer and dermatological disorders and methods for delivering formulations into the lung of a mammal suffering from emphysema, cancer and dermatological disorders.

REFERENCES:
patent: 5387594 (1995-02-01), Bernardon et al.
patent: 5439925 (1995-08-01), Bernardon et al.
patent: 5567721 (1996-10-01), Bernardon et al.
patent: 5597839 (1997-01-01), Bernardon et al.
patent: 5648503 (1997-07-01), Vuligonda et al.
patent: 5648514 (1997-07-01), Johnson et al.
patent: 5668156 (1997-09-01), Bernardon et al.
patent: 5688817 (1997-11-01), Bernardon et al.
patent: 6093742 (2000-07-01), Salituro et al.
patent: 6300350 (2001-10-01), Belloni et al.
patent: WO 9206948 (1992-04-01), None
patent: WO 0130326 (2001-05-01), None
Sof'ina et al. Experimental Evaluation of Antitumor Drugs in the USA and USSR and Clinical Correlations. NCI Monograph 55. NIH Publication No. 80-1933 (1980).*
Ebisawa, et al., “Novel Retinoidal Tropolone Derivatives. Bioisosteric Relationship of Tropolone Ring with Benzoic Acid Moiety in Retinoid Structure,”Chemical and Pharmaceutical Bulletin, (2001) pp 501-503, vol. 49:4.
Hashimoto, et al., “Evaluation of Differentiation—Inducing Activity of Retinoids on Human Leukemia Cell Lines HL-60 and NB4,”Biol. Pharm. Bull., (1996) pp 1322-1328, vol. 19:10.
Takagi, et al., “Inhibition of ornithine decarboxylase induction by retinobenzoic acids in relation to their binding affinities to cellular retinoid-binding proteins,”J. Cancer Res. Clin. Oncol. (1988) pp 221-224, vol. 114:3.

Affiliated with

Also associated with

Rating

Substituted urea retinoid agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted urea retinoid agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted urea retinoid agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3438252